Clinical Trial

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

Name: DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors — clinical trial record (NCT06953089)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

A Phase II, Multicenter, Open-Label Trial of DB-1311 in combination with BNT327 or DB-1305 in Participants with Advanced/Metastatic Solid Tumors

Protocol Amendment History 1 change

minor Trial arms changed: 8 -> 13 2026-05-23

Trial Details

NCT Number	NCT06953089
Lead Sponsor	DualityBio Inc. Collaborators: BioNTech SE
Conditions	Solid Tumors
Enrollment	450 participants
Start Date	2025-07-18
Primary Completion	2030-06-30 (estimated)
Study Completion	2030-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-05-22